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Introduction
Regulatory bodies around the world agree that 
breastfeeding provides the best nutrition for infants.1 
Exclusive breastfeeding is recommended by the World 
Health Organization (WHO) for the first six months, and 
supplemental breastfeeding for up to two years, or more. 
Although breastfeeding provides more benefits than formula 
feeding, many parents still choose infant formula as an 
alternative to the former.3,4 Human milk contains antibodies, 
hormones, enzymes, and many other components, which 
cannot be added to formula. However, additives with proven 
benefits, are added to modern day infant formulas.5
This article looks at the basics of prescribing infant formula. 
Serious medical cases, such as short bowl syndrome and 
malabsorption, are beyond the scope of this article.
Components of standard infant formulas
The nutritional composition of all infant formulas must meet 
the global standards as recommended by the European 
Society for Paediatric Gastroenterology, Hepatology and 
Nutrition’s (ESPGHAN) international expert group that was 
commissioned by The Codex Alimentarius Commission in 
November 2004. All infant formulas must contain sufficient 
amounts of basic nutrients, and are thus nutritionally 
interchangeable (Table I).  No evidence exists to recommend 
one brand over another.1,2
Prescribing the correct infant formula
Infant formulas developed as unmodified cows’ milk are not 
recommended for infants younger than 12 months of age, 
as they pose serious health risks.6,7
A wide variety of infant formulas are available, which makes 
choosing a suitable one difficult for parents and healthcare 
professionals. The majority of infants who are not being 
breastfed can use a standard infant formula, but a select 
few will require a more specialised formula. This will depend 
on gestational age and the presence of an illness.1
Table II provides a guide of available infant formulas, and 
indication of use. Formulas that are marketed for infants 
who are older than one year of age are not included, as 
no evidence exists to promote the use of such milk, or 
to demonstrate their superiority in terms of growth or 
development, when compared to whole milk.6
Casein- vs. whey-predominant infant formulas
Manufacturing companies market casein- or curd-
predominant formulas to “hungry” babies. However, there 
is no conclusive evidence that babies sleep longer, or have 
better quality sleep, if given such milk. These formulas form 
relatively indigestible curds in the stomach, and are not 
recommended for young babies.6
By comparison, whey-predominant infant formulas are more 
easily digested. Its composition of whey:casein (60:40)  is 
similar to that found in human milk. For this reason, whey-
predominant infant formulas are usually prescribed for 
newborn infants.6
Additional components added to infant 
formulas
As more human milk components are discovered, 
modifications to existing infant formula and new infant 
formulas are made.5 The European Society for Paediatric 
Gastroenterology, Hepatology and Nutrition’s (ESPGHAN) 
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international expert group, commissioned by The Codex 
Alimentarius Commission in November 2004, reported that 
the mere fact that a component is found in human milk, does 
not justify its addition to formula. Formula milk additives 
have to demonstrate that they provide a scientifically proven 
benefit.2
Long-chain polyunsaturated fatty acid 
supplementation
Alpha-linolenic acid (ALA) is the precursor for 
docosahexaenoic acid (DHA), more commonly referred to 
as omega-3 fatty acids. Linoleic acid (LA) is the precursor 
of arachidonic acid (AA), also known as omega-6 fatty 
acids. Omega-3 and omega-6 fatty acids are long-chain 
polyunsaturated fatty acids, important for neurological, 
cognitive, and visual development in the rapidly growing 
newborn.8  
DHA and AA are present in human milk, in variable amounts. 
However, until recently, infant formulas only contained their 
precursors, LA and ALA. The addition of LA and ALA to 
formulas is standard, and they have to be added to all infant 
formulas on ESPGHAN’s recommendation.1,2,9
In a recent Cochrane review, it was reported that the 
supplementation of DHA and AA in formula milk has 
not shown any beneficial effect with regard to the visual, 
physical, and neurodevelopment of term infants.2 Further 
research is needed before routine supplementation of DHA 
and AA in infant formulas can be recommended.2
Pre- and probiotics
Prebiotics, mostly in the form of indigestible oligosaccharides, 
are frequently added to infant formulas. Evidence that 
prebiotics reduce allergic disease is insufficient. Adding 
them is optional, providing they do not exceed 0.8g/ 
100 ml.10,11
The motivation for adding probiotics to infant formula is 
that they might have a positive effect on digestion, with 
regard to the frequency and duration of gastrointestinal 
infections, including acute rotavirus gastroenteritis. They 
might reduce the risk of antibiotic-associated diarrhoea 
developing, as well as improve immunity. When added to 
infant formulas,  Bifidobacterium lactis and Lactobacillus 
reuteri showed a significant decrease in the incidence and 
duration of diarrhoea caused by rotavirus.12 A systematic 
review conducted by ESPGHAN indicated that there is not 
enough evidence to recommend the addition of probiotics 
to infant formula.1
Nucleotides
A randomised control trial by Singhal et al found that 
healthy term infants fed nucleotide supplemented formulas 
experienced a greater weight increase and greater 
head circumference measurement compared to non-
supplemented formulas.13 ESPGHAN supports the addition 
of nucleotides to infant formula, provided that they do not 
exceed the maximum allowed amount of 5 mg/100 kcal.2,13,14
Table I: The European Society for Paediatric Gastroenterology, 
Hepatology and Nutrition’s recommended standards for the macro- and 
micronutrient composition of infant formula1
Component Minimum Maximum
Energy: kcal/100 ml 60 70
Protein: g/100 kcal
Cows’ milk
Soy 
Hydrolysed 
1.8
2.25
1.8a
3
3
3
Lipids: g/100 kcal
Total fat
Linoleic acid
α-linoleic acid
4.4
0.3
50
6.0
1.2
Not specified
Carbohydrates: g/100 kcal 9.0 14.0
Fat-soluble vitamins: µg/100 kcal (unless 
otherwise specified)
Vitamin A: µg RE/100 kcal (retinol 
equivalent) 
Vitamin D3
Vitamin E: mg α-TE/100 kcal (α-tocopherol 
equivalent )
Vitamin K
60
1
0.5
4
180
2.5
5
25
Water-soluble vitamins: µg/100 kcal 
(unless otherwise specified)
Thiamine
Riboflavin
Niacin 
Vitamin B6
Vitamin B12
Pantothenic acid
Folic acid 
Vitamin C: mg/100 kcal
Biotin
60
80
300
35
0.1
400
10
8
1.5
300
400
1 500
175
0.5
2 000
50
30
7.5
Minerals and trace elements: mg/100 
kcal
Iron (cows’ milk and hydrolysate protein)
Iron (soy-based protein)
Calcium
Phosphorus (cows’ milk and hydrolysate 
protein)
Phosphorus (soy-based protein)
Magnesium
Sodium
Chloride
Potassium
Minerals and trace elements: µg/100  
kcal
Manganese
Fluoride
Iodine
Selenium
Copper
Zinc
0.3b
0.45
50
25
30
5
20
50
60
1
Not specified
10
1
35
0.5
1.3
20
140
90
100
15
60
160
160
50
60
50
9
80
1.5
Other substances: mg/100 kcal
Choline
Myo-inositol
L-carnitine
7
4
1.2
50
40
Not specified
a =  If an infant formula is based on hydrolysed protein, and it contains less than 2.25g/100 kcal 
protein, it should be clinically tested.
b  = In areas where iron deficiency is proven, a higher iron content can be approved at national 
level.
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Table II:  Infant formula available in South Africa, and indication of use
Class Indication 
of use
Brand name Kcal/
100 ml
Protein source and g/100 ml Carbohydrates
and g/100 ml
Additives
Standard term 
infant formula
0-6 months of 
age, but can be 
used up to 12 
months of age
Healthy term 
infants, of normal 
birth weight
Nestlé, Nan 1® 67 Demineralised whey, 30:70 
whey-dominant, 1.23
Lactose, 7.47 DHAa, AAb, and nucleotides
Nestlé, Lactogen 1® 67 Demineralised whey,
55:45 casein-dominant, 1.51
Lactose, maltodextrin, 
7.46
-
Pfizer, S26 1® 67 Skimmed milk
40:60 whey-dominant, 1.5
Lactose, 7.2 -
Pfizer, S26 Gold 1® 67 Skimmed milk, 40:60  
whey-dominant, 1.5
Lactose, 7.2 DHA, AA, and
nucleotides
Pfizer, SMA 1® 67 Skimmed milk, 1.6
80:20 casein-dominant
Lactose, 7.0 -
Aspen, Infacare 1® 67 Whey protein, 40:60  
whey-dominant, 1.5
Glucose, lactose, 7.5 -
Aspen, Infacare 
Gold 1®
68 Whey protein, 40:60  
whey-dominant, 1.4
Lactose, 7.5 DHA, AA, and
nucleotides
Aspen, Infacare  
Nurture 1®
67 Whey protein, 40:60  
whey-dominant, 1.5
Lactose, 7.5 DHA and AA. 
Prebiotics and nucleotides
Pharmac, Novolac 1® 66.1 Demineralised whey,  
50:50 whey:casein, 1.5
Lactose, maltodextrin, 
7.5
-
Abbott, Similac 
Advance with Iron®
68 Whey protein, 1.4 Lactose, 7.3 DHA, AA, and
nucleotides
Standard term 
infant formula
6-12 months of 
age (not to be 
used for infants < 
6 months of age)
Healthy term infants 
older than 6 months 
of age
Nestlé, Nan 2® 67 Demineralised whey,
60:40 casein-dominant, 2.02
Lactose, 7.67 DHA
probiotics: Lactobacillus 
GG and Bifidobacterium 
longum
Nestlé, Lactogen 2® 67 Skim milk,
64:35 casein-dominant, 2.03
Lactose, maltodextrin, 
sucrose, 8.05
Probiotics: Lactobacillus 
reuteri
Pfizer, S26 Promil 2® 67 Whey protein, 60:40  
casein-dominant, 2.2
Lactose and  
sucrose, 8.2
Nucleotides
Pfizer, S26 Gold  
Promil 2®
67 Whey protein, 60:40  
casein-dominant, 2.2
Lactose and sucrose DHA, AA, and
nucleotides
Aspen, Infacare 2® 66 Whey protein, 65:35  
casein-dominant, 2.4
Sucrose and glucose 
syrup, 8.6
-
Aspen, Infacare 
Gold 2®
69 Whey protein, 50:50 
casein:whey
Lactose and sucrose DHA, AA, and
nucleotides
Aspen, Infacare  
Nuture 2®
67.3 Skim milk, 40:60 
casein-dominant
Lactose and sucrose, 
8.1
DHA, AA, and
nucleotides. Pre-and 
probiotics
Pharmaco, 
Novolac 2®
66 Skimmed milk, 80:20 
casein-dominant,1.6 
Lactose and 
maltodextrin, 7.7
-
Preterm formula Premature infants  
< 37 weeks 
gestation.
Birth weight  
< 2.5 kg
Nestlé, Pre nan 
powder®
80 30:70 whey, 2.3 Lactose, maltodextrin, 
8.57
DHA, AA and nucleotides
Nestlé, Pre nan 
ready to drink®
80 100% partially hydrolysed  
whey protein, 2.9
8.4 DHA, AA and nucleotides
Abbott, Similac Special 
Care 24Cal®
81 Skimmed milk, whey protein 
concentrate, 2.4
Lactose and corn syrup 
solids 8.4
DHA and AA
Abbott, Similac Special 
Care 20Cal®
68 Skimmed milk,  
whey protein, 2.0
Lactose and corn syrup 
solids, 7
DHA and AA
Soya formula
0-6 months of age
Primary lactase 
deficiency. 
Galactosaemia.
Vegetarian diet.
Abbott, Similac Isomil 
Advance®
68 Soy protein isolate, 1.66 Corn syrup and 
sucrose, 7.0
DHA and AA
Abbott, Isomil 1® 68 Soy protein isolate, 1.8 Corn syrup, sucrose, 
maltose, 6.9
-
Pfizer, Infasoy 1® 67 Soy protein isolate, 1.8 Corn syrup and sucrose -
Aspen, Infacare 
soya 1®
65 Soy protein isolate, 1.8 Corn syrup solids, 6.6 -
Aspen, Infacare 
Gold Soya 1®
67 Soy protein isolate Corn syrup solids DHA, AA, and nucleotides
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Class Indication 
of use
Brand name Kcal/
100 ml
Protein source and g/100 ml Carbohydrates
and g/100 ml
Additives
Soya formula
6-12 months of 
age
Primary lactase 
deficiency. 
Galactosaemia.
Vegetarian diet.
Abbott, Isomil 2® 69 Soy protein isolate,2.3 Corn syrup, sucrose 
and maltose, 8.0
-
Aspen, Infacare 
soya 2®
72 Soy protein isolate, 2.2 Corn syrup solids, 7.7 -
Aspen, Infacare 
Gold Soya 2®
- Soy protein isolate Corn syrup solids DHA, AA, and nucleotides
Pfizer, Infasoy 2® 66 Soy protein isolate, 2.5 Corn syrup and 
sucrose, 6.9
Nucleotides
Anti-reflux 
formula
Reflux associated 
with failure to 
thrive, respiratory 
symptoms and 
esophagitis
Nestlé, Nan AR® 67 Demineralised whey
30:70 casein-dominant, 1.24
Lactose, potato and 
corn starch, 7.7
-
Pharmaco, Novolac AR 
1 (Also AR 2)®
66 Skim milk, 80:20  
casein-dominant 1.7
Lactose and corn 
starch, 7.4
Long-chain 
polyunsaturated fatty acids
Aspen, Infacare AR® 67 Skim milk, 80:20  
casein-dominant, 1.6
Corn syrup solids, 
carob bean gum
-
Aspen, Infacare Nurture 
AR®
67 Skim milk, 80:20  
casein-dominant, 1.6
Corn syrup solids, 7.0 DHA, AA, and nucleotides
Acidified formula Infants with an 
increased risk 
of developing 
gastroenteritis
Nestlé, Nan Pelargon® 67 Demineralised whey, 50:50. 
1.49
Lactose, maltodextrin, 
7.57
Chemically acidified with 
lactic acid
Aspen, Melegi® 67 Whey protein, 40:60  
whey-dominant, 1.5
Corn syrup solids, 
lactose, 7.5
Chemically acidified with 
citric acid
Low-lactose or 
lactose-free
Galactosaemia. 
(However, not all 
of the formulas 
in this category 
are suitable for 
patients with 
galactosaemia).
Acute diarrhoea.
Lactose 
intolerance.
Nestle, Nan 
Lactose free®
67 Potassium caseinate, whey 
protein 40:60, whey-dominant, 
1.4
Corn syrup 
(maltodextrin), 7.8
DHA, AA, and nucleotides
Aspen, Infacare® 
Nurture LF® 
Not for galactosaemia.
67 Calcium caseinate, 1.5 Corn syrup solids, 7.2 DHA and AA.
Prebiotics
Hydrolysed cows’ 
milk formula
Limited research 
on the prevention 
of cows’ milk and 
other allergies 
(infants 0-6 months 
of age)
Nestlé, Nan HA® 1 (new) 67 100% partially hydrolysed whey 
protein, 1.51
Lactose, maltodextrin, 
7.56
DHA and AA
Limited research 
on the prevention 
of cows’ milk and 
other allergies 
(infants 6-12 
months of age)
Nestlé, Nan HA 2® 67 100% partially hydrolysed whey 
protein, 2.01
Lactose, maltodextrin, 8 DHA and AA.
Probiotics: Lactobacillus 
GG and 
Bifidobacterium longum
Limited research 
on the prevention 
of cows’ milk and 
other allergies 
(infants 0-12 
months of age)
Abbott, Similac 
Advanced HA®
71 26% degree of hydrolysis, 1.9 Maltodextrin, 7.9 Nucleotides
Pharmaco, 
Novolac HA®
65 16-22% degree of hydrolysis, 
1.6
Lactose, starch, 
glucose syrup, 7.6
-
Aspen, Infacare Nurture 
HA Comfort®
67 Hydrolysed whey, 1.5 Corn syrup, lactose, 7.2 DHA and AA.
Probiotics
Extensively 
hydrolysed 
formula
Diagnosed cows’ 
milk allergy, and 
other medical 
conditions
Nestlé, Alfaré® 70 100% whey protein extensively 
hydrolysed (80% small 
peptides, 20% free amino acids
Maltodextrin and potato 
starch 
DHA and nucleotides
Abbott, Similac 
Alimentum®
66.7 Extensively hydrolysed casein, 
supplemented with 60% free 
amino acids,1.8
Sucrose, modified 
tapioca, 6.8
DHA and AA
Cow’s milk protein 
allergy 0-6 months
Pharmaco, Novolac 
Allernova®
61.7 39 % degree of hydrolysis, 1.4 Glucose syrup. 6.7 -
Cow’s milk protein 
allergy
Nutricia, Pepticate® 66 Extensively hydrolysed whey, 
1.6 
Maltodextrin, 7.1 DHA, AA, and nucleotides
CPD: The basics of prescribing infant formulas
29 Vol 54 No 1S Afr Fam Pract 2012
Specialised formulas
In a small percentage of cases, due to feeding intolerances, 
infants require specialised formulas. This should only be 
given on the recommendation of a dietitian or physician.1
Protein-modified formula
Preventing cows’ milk allergies, as well as others
There is no evidence to support giving hydrolysed cows’ 
milk over exclusive breast milk in an attempt to prevent 
allergies in infants.  Limited evidence exists to support 
giving hypoallergenic (partially hydrolysed or extensively 
hydrolysed) formula vs. cows’ milk formula to infants at high 
risk of developing allergies.15
Evidence indicates that giving soy-based formula, rather 
than cow’s milk formula, does not reduce the risk of the 
development of allergies such as asthma, eczema, rhinitis, 
and cow’s milk allergy, in later infancy and childhood.16,17
Treatment of cows’ milk allergies
Where exclusive breastfeeding is not possible, extensively 
hydrolysed cows’ milk protein formulas and amino acid-
based formulas should be given to treat infants with 
diagnosed cows’ milk protein allergies. Amino acid-based 
formulas should be given to infants who are highly allergic.18
Treatment of colic
The authors of a recent Cochrane review concluded that 
there is some evidence to promote offering hydrosylate 
cow’s milk formula to bottle-fed infants suffering from 
colic.19  However, the recommendation is based on a small 
randomised control trial, and further research is required. 
Soy infant formulas should not be given to prevent or treat 
colic.17
Soy-based infant formula
Cows’ milk protein allergy (CMPA) is a major financially 
driven indication for soy formulas to be given, but giving 
hydrolysed cow’s milk protein formula and amino acid-based 
formula has proven to be more effective, and should be 
the first option in treating CMPA. ESPAGHAN recommends 
that there should be a transition from hydrolysed cow’s milk 
protein formula to soy-based formula after six months of age, 
as it is better tolerated by older infants. The viewpoint of the 
American Academy of Paediatrics (AAP) is as follows: “…
for infants with documented CMPA, extensively hydrolysed 
protein formula should be considered, because 10-14% of 
these infants will also have a soy protein allergy.”17
The only medical indication for giving soy infant formulas is 
galactosaemia and primary lactase deficiency.  ESPGHAN 
and the AAP recommend a lactose-containing formula for 
realimentation, but a lactose-free formula is better tolerated 
in infants with secondary lactose intolerance after acute 
gastroenteritis. This has encouraged the consumption of 
isolated soy-based infant formula, but research has shown 
that the use of lactose-free formula is also well tolerated.17
Carbohydrate-modified formula
The major carbohydrate in breast milk and standard cows’ 
milk formula is lactose. Strong evidence suggests that 
a lactose-free infant formula is effective in the dietary 
management of acute diarrhoea.17 Galactose and glucose 
make up lactose, and therefore, infants with galactosaemia 
require a lactose-free infant formula, and cannot be 
breastfed.20
Acidified formula
Infant formula can be chemically acidified through the 
addition of L (+) lactic acid, or biologically through 
fermentation, which transforms lactose into lactic acid. 
The method of acidification does not have an effect on 
the growth of infants. The growth of pathogenic bacteria is 
inhibited through the use of an acidified formula, leading to 
a decreased incidence of diarrhoea in infants.20
Preterm milk
Human milk is the best source of nutrition for all infants, 
including infants who are born prematurely.21,22 An 
Class Indication 
of use
Brand name Kcal/
100 ml
Protein source and g/100 ml Carbohydrates
and g/100 ml
Additives
Free amino  
acid-based 
formula
Highly allergic 
infant. 
Other conditions 
where an elemental 
diet may be 
indicated.
Nutricia, Neocate® 71 Free amino acids, 1.95 Glucose, syrup, 8.1 -
Highly allergic 
infant. 
Other conditions 
where an elemental 
diet may be 
indicated. Children 
> 1 year of age.
Nutricia, Neocate 
advanced®
100 Free amino acids, 2.5 Glucose syrup, 14.6 -
a = docosahexaenoic acid, b = arachidonic acid
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appropriate preterm formula should be prescribed by a 
neonatologist on an individualised basis, to premature 
infants who cannot be breastfed. It should be given in 
the early months, after birth.23 Continuous nutritional 
intervention post-discharge must be encouraged, and is of 
vital importance.24
Anti-reflux formula
Almost half of all infants are affected by symptomatic 
gastroesophageal reflux (GER). Uncomplicated GER usually 
resolves spontaneously, and needs no treatment. Infants with 
GER presenting with failure to thrive, and esophagitis and 
respiratory complications, typically need pharmacological, 
or other treatment. Non pharmacological treatment includes 
giving an infant formula that is pre-thickened with pre-
cooked corn starch or locust bean gum, which has been 
proven to decrease episodes of regurgitation and emesis. 
Pre-thickened formula is nutritionally safe, and contains 
adequate amounts of the necessary nutrients.1,14,25,26
Follow-on milk for infants aged six to 12 months
Giving follow-on milk was deemed “not necessary” by the 
World Health Assembly. The United Nations Children’s 
Fund’s (UNICEF) position is that parents can continue to 
give first milk until an infant reaches 12 months of age. 
First milk, together with complimentary foods, will provide 
enough nutrients to satisfy a healthy infant’s nutritional 
needs.6
Conclusion
Breastfeeding is the best source of nutrition for most 
infants, and should be promoted, supported, and 
protected at all times. In rare cases, for example, infants 
with galactosaemia or primary lactase deficiency, or for 
any other medical reasons where the mother is unable, or 
unwilling, to breastfeed, it is important to select a suitable 
infant formula based on the infant’s individual needs, and 
medical condition.
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